In i-DREAMS (2019–2023), they worked on safety tolerance zone calculation and real-time interventions for driver-vehicle-environment interactions.
CARDIOID TECHNOLOGIES LDA
Portuguese tech SME specialising in driver behaviour monitoring, automated vehicle safety, and verification of safety-critical systems.
Their core work
Cardioid Technologies is a Portuguese technology SME specializing in safety systems for road transport and automated vehicles. Their work focuses on monitoring driver behavior, calculating safety tolerance zones, and developing interventions for driver-vehicle-environment interactions — essentially building the intelligence layer that detects when a driver or automated system is approaching unsafe states. In parallel, they contribute to the formal verification and validation of automated systems, ensuring that safety-critical software meets rigorous standards before deployment. Their profile suggests a company with hands-on technical capability in sensing, data analysis, and safety engineering for the mobility sector.
What they specialise in
In VALU3S (2020–2023), they contributed to frameworks for validating the safety and security of automated systems — a methodologically distinct but complementary capability.
Both projects sit at the intersection of vehicle automation and safety, covering human-machine interaction in i-DREAMS and system-level assurance in VALU3S.
VALU3S introduced formal testing and V&V methodologies, suggesting a growing capability in software assurance for safety-critical domains.
How they've shifted over time
Cardioid Technologies entered H2020 focused squarely on the human side of road safety — driver behaviour, vehicle automation, and safety tolerance in real-world driving conditions. Within a year, they added a second, more methodological thread: the formal verification and validation of automated systems, which moves from observing human drivers to certifying the machines themselves. The shift from early keywords like "driver behaviour" and "road safety" to later ones like "verification and validation" and "automated systems" traces a logical progression — from monitoring whether a system is safe in practice, to proving it is safe by design.
Cardioid Technologies appears to be moving toward the formal assurance side of automated mobility — V&V, testing frameworks, and safety certification — which positions them well for future projects in autonomous vehicles, urban air mobility, or safety-critical embedded systems requiring regulatory compliance.
How they like to work
Cardioid Technologies has participated exclusively as a consortium partner — never as coordinator — across both H2020 projects, indicating a preference or current capacity suited to specialist contribution rather than project leadership. Despite only two projects, they have engaged with 53 distinct partners across 15 countries, suggesting they integrate well into large, multi-national research consortia. This broad partner exposure in a short time points to an organisation that is active and visible in its niche, even without holding the coordinator role.
Cardioid Technologies has built a surprisingly wide network for a two-project SME — 53 unique partners across 15 countries, all through RIA consortia in transport and digital sectors. Their network spans the breadth of European transport research, giving them connections across universities, research institutes, and industry players active in road safety and automated mobility.
What sets them apart
Cardioid Technologies occupies a specific niche at the boundary between human-factors road safety and formal automated systems assurance — two areas that are increasingly converging as vehicles become more automated. As a Portuguese SME based in Matosinhos (near Porto), they bring geographic diversity to consortia that tend to be dominated by northern and central European partners, while their dual transport/digital sector profile makes them a natural bridge between mobility engineering and software validation communities. For a consortium building a project around ADAS, autonomous vehicles, or safety-critical embedded systems, they offer targeted technical depth without the overhead of a large institution.
Highlights from their portfolio
- i-DREAMSTheir largest project by far at EUR 539,375, focused on real-time safety monitoring for drivers and automated vehicles — a high-impact applied research area directly linked to EU road safety targets.
- VALU3SThough smaller in funding (EUR 68,054), VALU3S addresses a critical bottleneck in automated systems deployment — standardised V&V frameworks — marking Cardioid's entry into the safety certification space.